BioSpace News Archive

QIAGEN Expands Next-Generation Sequencing Portfolio with Oncology and Immuno-Oncology Panels for Research Using GeneReader NGS System and Other Platforms

Sample to Insight solutions enabling deep analysis of disease-related genomic mutations

October 29, 2018
·
2 min read
Business

QIAGEN Reports Results for Third Quarter and First Nine Months of 2018

Q3 2018 results exceed targets as QIAGEN on track to achieve 2018 goals

October 29, 2018
·
1 min read
Biotech Beach

Baxter Highlights Clinical Data at ASN: Kidney Week Showing How New Technologies Are Advancing Dialysis Care across Modalities

Thirteen studies presented on HDx therapy enabled by Theranova adding to significantly growing global clinical evidence

October 29, 2018
·
8 min read
Business

Greenbrook TMS Announces Dates for Its Third Quarter 2018 Results

Greenbrook TMS Inc. will release its third quarter 2018 operational and financial results after market hours on November 12, 2018.

October 29, 2018
·
1 min read
Business

Karius and Dasa enter into a partnership to introduce the Karius Test into Brazil

Karius, a life sciences company transforming infectious disease diagnostics with genomics, is forming a partnership with Dasa, the largest medical diagnostic company in Latin America, effective October 19, 2018.

October 29, 2018
·
2 min read
Business

Healogics Aims to Raise Awareness of Diabetic Foot Ulcers and Recurrence

Healogics®, the nation’s wound healing expert, is proud to participate in a national diabetes awareness campaign October 29 through November 2

October 29, 2018
·
3 min read
Drug Development

CStone announces first patient dosed in Phase I study in China for MEK inhibitor CS3006

CStone Pharmaceuticals (CStone) today announced the initiation in China of a Phase I clinical trial for CS3006, a small-molecule MEK1/2 inhibitor.

October 29, 2018
·
3 min read
BioForest

New Study Reveals Teens 16 Times More Likely to Use JUUL than Older Age Groups

Truth Initiative® Releases Data from a First-of-Its-Kind Study that Explores the Rates and Characteristics of JUUL Use

October 29, 2018
·
4 min read
BioForest

Receptor Holdings, Inc. Secures $29 Million Funding Round

Receptor Holdings, Inc. and Receptor Life Sciences announced that it raised $29 million in a combined convertible debt and Series A round of financing.

October 29, 2018
·
2 min read
Biotech Beach

Endologix, Inc. to Present at Two Investor Conferences in November

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will present at the following two investor conferences in November:

October 29, 2018
·
1 min read